Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1919-1931
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1919
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1919
Table 10 Comparison of CD4+ T cell count in control and intervention groups before and after autologous bone marrow infusion
| Group | Before | 1 mo | t/P value | 3 mo | t/P value | 6 mo | t/P value | 12 mo | t/P value |
| Control | 432 ± 190 | 432 ± 183 | 0.384/0.703 | 440 ± 184 | 2.805/0.008 | 445 ± 189 | 5.259/0.000 | 447 ± 186 | 4.796/0.000 |
| Intervention | 436 ± 243 | 487 ± 227 | 9.029/0.000 | 492 ± 219 | 8.140/0.000 | 507 ± 223 | 10.150/0.000 | 510 ± 213 | 8.566/0.000 |
| t | 0.106 | 1.177 | 1.148 | 1.329 | 1.400 | ||||
| P value | 0.916 | 0.243 | 0.255 | 0.188 | 0.166 |
- Citation: Liu BC, Cheng MR, Lang L, Li L, Si YH, Li AJ, Xu Q, Zhang H. Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study. World J Gastrointest Surg 2023; 15(9): 1919-1931
- URL: https://www.wjgnet.com/1948-9366/full/v15/i9/1919.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i9.1919